These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22705838)

  • 1. Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool.
    Pérez Brandan C; Basombrío MÁ
    Bioengineered; 2012; 3(4):242-6. PubMed ID: 22705838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.
    Perez Brandan C; Padilla AM; Xu D; Tarleton RL; Basombrio MA
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1418. PubMed ID: 22180798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
    Quijano-Hernández IA; Castro-Barcena A; Vázquez-Chagoyán JC; Bolio-González ME; Ortega-López J; Dumonteil E
    Vaccine; 2013 Apr; 31(18):2246-52. PubMed ID: 23499599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutical effects of vaccine from Trypanosoma cruzi amastigote surface protein 2 by simultaneous inoculation with live parasites.
    Ribeiro FAP; Pontes C; Machado AMV; Bruna-Romero O; Quintana HT; De Oliveira F; De Vasconcelos JRC; Ribeiro DA
    J Cell Biochem; 2019 Mar; 120(3):3373-3383. PubMed ID: 30246366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.
    Collins MH; Craft JM; Bustamante JM; Tarleton RL
    Infect Immun; 2011 Aug; 79(8):3397-406. PubMed ID: 21628516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
    Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ
    PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi.
    Zago MP; Barrio AB; Cardozo RM; Duffy T; Schijman AG; Basombrío MA
    Infect Immun; 2008 Jan; 76(1):443-51. PubMed ID: 17938222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
    Aparicio-Burgos JE; Zepeda-Escobar JA; de Oca-Jimenez RM; Estrada-Franco JG; Barbabosa-Pliego A; Ochoa-García L; Alejandre-Aguilar R; Rivas N; Peñuelas-Rivas G; Val-Arreola M; Gupta S; Salazar-García F; Garg NJ; Vázquez-Chagoyán JC
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003625. PubMed ID: 25853654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.
    Basso B; Castro I; Introini V; Gil P; Truyens C; Moretti E
    Vaccine; 2007 May; 25(19):3855-8. PubMed ID: 17349724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.
    Chamekh M; Vercruysse V; Habib M; Lorent M; Goldman M; Allaoui A; Vray B
    Infect Immun; 2005 Oct; 73(10):6552-61. PubMed ID: 16177330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Córdoba, Argentina.
    Basso B; Marini V; Gauna D; Frias M
    Mem Inst Oswaldo Cruz; 2016 Apr; 111(4):271-4. PubMed ID: 27074257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.